Sustained release of 5-fluorouracil from oil/water emulsions. 1992

M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
Department of Pharmacology and Toxicology, Tohoku College of Pharmacy, Sendai, Japan.

Release profile of 5-fluorouracil (5-FU) from O/W emulsion and bone marrow toxicity of 5-FU to mice were compared with those of an aqueous solution of 5-FU. 5-FU emulsion had lower bone marrow toxicity and a slower drug release rate than the 5-FU aqueous solution which exhibited high bone marrow toxicity and fast drug release rate. A correlation between the rate of drug release and bone marrow toxicity was suggested.

UI MeSH Term Description Entries
D009821 Oils Unctuous combustible substances that are liquid or easily liquefiable on warming, and are soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. Depending on their behavior on heating, they are volatile or fixed. (Dorland, 28th ed)
D001855 Bone Marrow Diseases Diseases involving the BONE MARROW. Bone Marrow Disease,Disease, Bone Marrow,Diseases, Bone Marrow,Marrow Disease, Bone,Marrow Diseases, Bone
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
December 2000, The Journal of pharmacy and pharmacology,
M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
September 1996, Ophthalmic surgery and lasers,
M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
November 1992, Investigative ophthalmology & visual science,
M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
January 1989, Journal of ocular pharmacology,
M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
January 1989, Biopharmaceutics & drug disposition,
M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
May 1992, Journal of pharmaceutical sciences,
M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
July 2008, Langmuir : the ACS journal of surfaces and colloids,
M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
January 1987, Journal of parenteral science and technology : a publication of the Parenteral Drug Association,
M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
September 1977, Chemical & pharmaceutical bulletin,
M Ishikawa, and H Kikuta, and A Imaizumi, and E Suzuki, and Y Takayanagi, and K Sasaki
January 1968, Journal of pharmaceutical sciences,
Copied contents to your clipboard!